Dashboard
Manage Tickers

TEVATEVA PHARMACEUTICAL INDUSTR...

NYSE tevapharm.com


$ 16.84 $ 0.03 (0.18 %)    

Monday, 10-Jun-2024 15:59:51 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 464.61 $ 1.87 (0.4 %)
DIA $ 389.34 $ 0.80 (0.21 %)
SPY $ 535.72 $ 1.65 (0.31 %)
TLT $ 90.89 $ -0.61 (-0.67 %)
GLD $ 213.56 $ 1.94 (0.92 %)
$ 16.85
$ 16.74
$ 0.00 x 0
$ 16.86 x 100
$ 16.59 - $ 16.93
$ 7.27 - $ 17.39
8,188,851
na
19.08B
$ 1.13
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-12-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 02-10-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 07-27-2022 06-30-2022 10-Q
9 05-03-2022 03-31-2022 10-Q
10 02-09-2022 12-31-2021 10-K
11 10-27-2021 09-30-2021 10-Q
12 07-28-2021 06-30-2021 10-Q
13 04-28-2021 03-31-2021 10-Q
14 02-10-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-21-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-19-2019 12-31-2018 10-K
23 11-01-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-03-2018 03-31-2018 10-Q
26 02-12-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

barclays-maintains-overweight-on-teva-pharmaceutical-indus-raises-price-target-to-21
Barclays Maintains Overweight on Teva Phar...
06/05/2024 15:20:00

Barclays analyst Balaji Prasad maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Overweight and raises the price target...

teva-announced-saturday-switching-to-uzedy-at-four-weeks-after-the-last-dose-of-once-monthly-paliperidone-palmitate-provided-the-most-comparable-pharmacokinetic-profile-based-on-the-relevant-pk-modeling-data-for-schizophrenia
Teva Announced Saturday, Switching To UZED...
06/02/2024 18:33:49

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA),today announced the present...

4-analysts-assess-teva-pharmaceutical-indus-what-you-need-to-know
4 Analysts Assess Teva Pharmaceutical Indu...
05/30/2024 16:01:09

b-of-a-securities-maintains-buy-on-teva-pharmaceutical-indus-raises-price-target-to-21
B of A Securities Maintains Buy on Teva Ph...
05/30/2024 15:45:08

B of A Securities analyst Jason Gerberry maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Buy and raises the price tar...

reported-earlier-tevas-austedo-xr-receives-fda-green-light-one-pill-once-daily-dosage-now-available-for-td-and-hd-chorea
Reported Earlier, Teva's AUSTEDO XR Receiv...
05/30/2024 07:16:14

U.S. FDA approves new one pill, once-daily AUSTEDO XR tablets (30, 36, 42, 48 mg/day) AUSTEDO XR offers more flexibility wit...

teva-pharmaceutical-induss-options-frenzy-what-you-need-to-know
Teva Pharmaceutical Indus's Options Frenzy...
05/22/2024 16:01:48

Core News & Articles
Reported Earlier, Teva And Alvotech Announ...
05/21/2024 06:57:27

cannabis-meets-prescription-drugs-steroids-and-ketamine-in-schedule-iii-what-it-means-key-stocks-to-watch
Cannabis Meets Prescription Drugs, Steroid...
05/18/2024 14:19:14

President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled ...

piper-sandler-reiterates-overweight-on-teva-pharmaceutical-indus-raises-price-target-to-20
Piper Sandler Reiterates Overweight on Tev...
05/13/2024 12:46:08

Piper Sandler analyst David Amsellem reiterates Teva Pharmaceutical Indus (NYSE:TEVA) with a Overweight and raises the price...

these-10-large-cap-stocks-shined-brightest-last-week-may-5-may-11-2024-are-they-in-your-portfolio
These 10 Large Cap Stocks Shined Brightest...
05/12/2024 17:33:47

Toast, Teva, Vistra, Equinix, Applovin, IFF, Constellation, Emerson, IP, and STERIS were top performers last week. Are they in ...

barclays-maintains-overweight-on-teva-pharmaceutical-indus-raises-price-target-to-20
Barclays Maintains Overweight on Teva Phar...
05/09/2024 15:42:06

Barclays analyst Balaji Prasad maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Overweight and raises the price target...

generics-player-teva-pharmaceutical-aces-late-stage-schizophrenia-drug-study-stock-shoots-higher
Generics Player Teva Pharmaceutical Aces L...
05/08/2024 17:49:15

Results from the Phase 3 SOLARIS trial of TEV-‘749 for schizophrenia treatment. SteadyTeq technology ensures controlled olanzap...

why-upstart-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Upstart Shares Are Trading Lower By Ar...
05/08/2024 17:38:56

louisiana-pacific-posts-upbeat-results-joins-cricut-elanco-animal-american-public-education-and-other-big-stocks-moving-higher-on-wednesday
Louisiana-Pacific Posts Upbeat Results, Jo...
05/08/2024 15:11:22

wall-street-poised-for-muted-open-on-mixed-earnings-with-more-fed-speeches-in-store-analyst-sees-sp-500-crossing-late-march-high
Wall Street Poised For Muted Open On Mixed...
05/08/2024 11:13:23

U.S. stocks are on track for a mixed start on Wednesday as the market digests mixed earnings reports and looks ahead to more sp...

teva-pharmaceutical-indus-q1-2024-adj-eps-048-misses-051-estimate-sales-3819b-beat-3732b-estimate
Teva Pharmaceutical Indus Q1 2024 Adj EPS ...
05/08/2024 11:02:23

teva-pharmaceuticals-and-medincell-say-phase-3-efficacy-results-from-solaris-trial-for-schizophrenia-showed-that-tev-749-met-its-primary-endpoint-as-measured-by-a-change-in-the-panss-total-score-from-baseline-after-8-weeks-compared-to-placebo
Teva Pharmaceuticals And Medincell Say Pha...
05/08/2024 10:38:42

The study met its primary endpoint achieving clinically meaningful and statistically significant reductions across all TEV-‘7...

investor-sentiment-falls-further-dow-gains-for-fifth-session
Investor Sentiment Falls Further, Dow Gain...
05/08/2024 07:49:03

uber-lyft-and-3-stocks-to-watch-heading-into-wednesday
Uber, Lyft And 3 Stocks To Watch Heading I...
05/08/2024 07:31:10

will-earnings-cheer-continue-this-week-all-eyes-on-disney-palantir-robinhood-while-reddit-gears-up-for-debut-quarterly-report
Will Earnings Cheer Continue This Week? Al...
05/06/2024 09:25:15

According to FactSet, a financial data analytics firm, 80% of S&P 500 companies have reported earnings so far.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)